These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8325306)

  • 1. Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarction.
    Pedersen OD; Munkvad S; Gram J; Kluft C; Jespersen J
    Eur Heart J; 1993 Jun; 14(6):785-9. PubMed ID: 8325306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapy.
    Munkvad S; Jespersen J; Gram J; Kluft C
    J Am Coll Cardiol; 1991 Aug; 18(2):454-8. PubMed ID: 1906904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study.
    Munkvad S; Jespersen J; Gram J; Kluft C
    J Am Coll Cardiol; 1991 Mar; 17(4):957-62. PubMed ID: 1900313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
    Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarction.
    Kluft C; Munkvad S; Gram J; Jespersen J
    Agents Actions Suppl; 1992; 38 ( Pt 2)():299-304. PubMed ID: 1462835
    [No Abstract]   [Full Text] [Related]  

  • 7. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
    Jansson JH; Nilsson TK; Johnson O
    Br Heart J; 1991 Nov; 66(5):351-5. PubMed ID: 1747294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction.
    Lodi S; Isa L; Pollini E; Bravo AF; Scalvini A
    Scand J Haematol; 1984 Jul; 33(1):80-2. PubMed ID: 6463588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women.
    Siegerink B; Rosendaal FR; Algra A
    J Thromb Haemost; 2014 May; 12(5):606-13. PubMed ID: 24977287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction.
    Gram J; Jespersen J; Kluft C; Rijken DC
    Acta Med Scand; 1987; 221(2):149-53. PubMed ID: 3591453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
    Tsuda H; Miyata T; Iwanaga S; Yamamoto T
    Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.
    Kluft C; Wijngaards G; Jie AF
    J Lab Clin Med; 1984 Mar; 103(3):408-19. PubMed ID: 6199446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical review of the relationship between impaired fibrinolysis and myocardial infarction.
    Prins MH; Hirsh J
    Am Heart J; 1991 Aug; 122(2):545-51. PubMed ID: 1858639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.